A 26-year-old woman3 months post-partum was admitted to our hospital suffering from gross visual disturbance. Magnetic resonance imaging (MRI) revealed a pituitary mass, extending into the suprasellar cistern, with intense gadolinium enhancement. Lymphocytic hypophysitis (LHy) was suspected, and the patient received high dose methylprednisolone pulse therapy (HDMPT). Her visual disturbance was dramatically ameliorated on the first day following initiation of HDMPT,and MRI revealed marked mass reduction. Her pituitary function recovered 6 months after therapy. This case report suggests that HDMPT proved effective for mass reduction of severe LHyand could obviate the need for a useless surgery.
Introduction
Lymphocytic hypophysitis (LHy) is a rare autoimmune disease, usually diagnosed following pituitary biopsy, or diagnosed unexpectedly during assessment for a presumed pituitary adenoma. Recently, corticosteroid therapy has been recommendedwhen LHy is suspected clinically, even without pathological confirmation (1, 2) . Although high dose (1 mg/body weight) prednisolone is usually preferred in order to allow quick evaluation of the therapeutic response, when gross visual disturbance is present, the response time maybe delayed. In fact, gross visual disturbance may be potentially At the time of admission, the patient was 159.2 cm tall and weighed 51.2 kg. Her blood pressure was 1 10/60 mmHg, with a pulse rate of 84/min. No goiter or enlargement of lymph nodes was noted. The remainder of the examination was unremarkable. Laboratory findings on admission revealed mild normochromic anemia as shown in Table 1 . Her corrected visual acuity was 0.1 in the right eye and 0.01 in the left eye, and critical fusion frequency (CFF) was low, particularly in the left eye (right 41 Hz, left 10 Hz). In the MRI study performed on January 15, the sagittal Tl-weighted image of contrast material revealed a mass enlarging the sella turcica extending into the suprasellar cistern, and abutting the optic chiasm (Fig. 1A) . The mass showed intense enhancementafter administration of contrast material. The clinical course and MRIfindings were suspicious for LHy.
The patient's visual impairment was severe enough to Although such surgery in LHy leads to rapid relief of neurological symptoms, it is deleterious on the pituitary function. Further, because the patient hopedto conceive another infant, we decided to perform surgery only if she did not respond to steroid therapy. The patient agreed with treatment plan. Therefore, we administered HDMPT (1 g methylprednisolone daily for three days). One-day status-post HDMPT initiation, the patient's visual sensation become clear and her headache was dramatically improved. MRI taken 3 days later revealed marked mass reduction ( prednisolone (50 mg daily) were initiated and tapered gradually without recurrence of the disease on low-dose prednisolone (10 mg daily) (Fig. 3) .
Endocrine assessment prior to the initiation of steroid therapy revealed low free thyroxine (0.6 | ug/dl), low thyrotropin (0.25 plU/ml), and a low, blunted thyrotropin response to thyrotropin releasing hormone (TRH) ( Fig. 2A) proved to be blunted during provocative testing. Posterior pituitary function was deemednormal because she had normal urine output with a urinary osmolality of 638 mOsm/kgH2O, and antidiuretic hormone was 3.67 pg/ml. Furthermore, she had normal urine output even after initiation of steroid therapy. Neither anti-thyroid nor anti rat pituitary antibodies were detected. Endocrinological examination 6 months after initiation of steroid therapy revealed normalization of thyroid function and normal TSHand ACTHresponses to provocative testing. The GH response to GH releasing hormone (GRH) was marked (Fig. 2B ).
Discussion
LHyis a rare autoimmune disease, usually diagnosed by pituitary biopsy or unexpectedly during the work-up for a presumed pituitary adenoma. Recently, it has been proposed that the diagnosis of LHycan be madewithout pathological confirmation in a high proportion of patients (3) . In this set- (tuberculosis and sarcoidosis) were helpful for rule out sarcoidosis, tuberculosis, and syphilis. While it is impossible to completely differentiate primary granulomatous hypophysitis from LHy without pituitary biopsy, it has been suggested that LHy and primary granulomatous hypophysitis may, in fact, be different manifestations of the same disease (6) . Wesuggest that response to high dose HDMPT may help to confirm the diagnosis of LHy by inducing rapid mass regression, thereby avoiding useless surgery.
Antipituitary antibody testing by immunofluorescence using pituitary tissue from a rat was negative in the present case. However, this testing cannot be a positive marker for LHy because it has been reported that this testing is nonspecific and the antibody is believed to be of low titer. Recently, it has been reported that autoantibodies to a 22-kDa human pituitary cytosolic protein by immunoblotting could be a marker for LHy, and this diagnostic method certainly shows promise (7) .
Corticosteroid therapy appears to be the logical treatment of LHy, as it has been used with success in various autoimmunediseases. However, controversy still surrounds the duration of treatment and appropriate dosage. Although surgery for mass effect in LHyleads to rapid relief of neurological symptoms, it is deleterious to pituitary function. Therefore, surgery should be avoided when LHy is suspected clinically, and initiation of corticosteroid therapy should be considered. Although a replacement dose or a high dose of corticosteroid (1 mg/body weight of prednisolone) has been used thus far, it may take more time to prompt a favorable response. The present patient's visual impairment was so severe that wehad to relieve the mass effect morequickly.
Therefore, we chose to administer HDMPT. Our patient had an extremely favorable response to this plan of action. Questions remain regarding the necessity of HDMPTin this case, because previous reports have discussed the efficacy of a replacement dose or high doses of corticosteroid for pituitary mass reduction. However, considering that our patient's symptomsand MRIfindings relapsed upon tapering the dose of prednisolone to 25 mg daily, there appears to be a great likelihood that our patient would not have had an adequate response to high dose prednisolone, such as 50 mg/day. suggests that methylprednisolone pulse therapy was effective for mass reduction of severe LHyand could allow patients to avoid useless surgery.
